Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HKD6
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.316 |
CLV_NRD_NRD_1 | 157 | 159 | PF00675 | 0.304 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.323 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.150 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.530 |
CLV_NRD_NRD_1 | 95 | 97 | PF00675 | 0.284 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.332 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.319 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.246 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.381 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.494 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.357 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.523 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.286 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.269 |
CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.339 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.413 |
CLV_PCSK_PC1ET2_1 | 59 | 61 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 95 | 97 | PF00082 | 0.286 |
CLV_PCSK_PC7_1 | 147 | 153 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.577 |
CLV_PCSK_SKI1_1 | 69 | 73 | PF00082 | 0.338 |
DOC_PP1_SILK_1 | 76 | 81 | PF00149 | 0.203 |
DOC_USP7_MATH_1 | 157 | 161 | PF00917 | 0.413 |
DOC_USP7_MATH_1 | 174 | 178 | PF00917 | 0.327 |
DOC_USP7_UBL2_3 | 167 | 171 | PF12436 | 0.413 |
DOC_USP7_UBL2_3 | 93 | 97 | PF12436 | 0.300 |
LIG_14-3-3_CanoR_1 | 102 | 109 | PF00244 | 0.301 |
LIG_14-3-3_CanoR_1 | 161 | 165 | PF00244 | 0.203 |
LIG_14-3-3_CanoR_1 | 26 | 30 | PF00244 | 0.507 |
LIG_14-3-3_CanoR_1 | 66 | 75 | PF00244 | 0.203 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.682 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.203 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.276 |
LIG_FHA_2 | 26 | 32 | PF00498 | 0.539 |
LIG_FHA_2 | 87 | 93 | PF00498 | 0.296 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.298 |
LIG_REV1ctd_RIR_1 | 18 | 27 | PF16727 | 0.554 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.362 |
LIG_SH2_CRK | 47 | 51 | PF00017 | 0.301 |
LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.433 |
LIG_SH2_STAP1 | 84 | 88 | PF00017 | 0.301 |
LIG_TRAF2_1 | 71 | 74 | PF00917 | 0.203 |
LIG_UBA3_1 | 183 | 189 | PF00899 | 0.301 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.310 |
MOD_CK1_1 | 160 | 166 | PF00069 | 0.263 |
MOD_CK2_1 | 121 | 127 | PF00069 | 0.337 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.410 |
MOD_CK2_1 | 25 | 31 | PF00069 | 0.505 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.372 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.218 |
MOD_Cter_Amidation | 32 | 35 | PF01082 | 0.533 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.331 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.358 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.311 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.415 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.283 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.373 |
MOD_PKA_1 | 102 | 108 | PF00069 | 0.301 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.468 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.501 |
MOD_PKA_2 | 67 | 73 | PF00069 | 0.203 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.305 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.271 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.246 |
MOD_Plk_4 | 179 | 185 | PF00069 | 0.354 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.473 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.244 |
MOD_SUMO_for_1 | 13 | 16 | PF00179 | 0.483 |
TRG_DiLeu_BaEn_3 | 73 | 79 | PF01217 | 0.203 |
TRG_ENDOCYTIC_2 | 120 | 123 | PF00928 | 0.384 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.314 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.283 |
TRG_NLS_Bipartite_1 | 115 | 135 | PF00514 | 0.203 |
TRG_NLS_Bipartite_1 | 151 | 171 | PF00514 | 0.370 |
TRG_NLS_MonoCore_2 | 93 | 98 | PF00514 | 0.301 |
TRG_NLS_MonoExtC_3 | 130 | 135 | PF00514 | 0.306 |
TRG_NLS_MonoExtC_3 | 166 | 171 | PF00514 | 0.413 |
TRG_NLS_MonoExtN_4 | 93 | 99 | PF00514 | 0.301 |
TRG_Pf-PMV_PEXEL_1 | 48 | 53 | PF00026 | 0.314 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMW6 | Leptomonas seymouri | 78% | 100% |
A0A0S4J953 | Bodo saltans | 47% | 84% |
A0A1X0NUH7 | Trypanosomatidae | 54% | 96% |
A0A3R7KF30 | Trypanosoma rangeli | 52% | 96% |
A0A3S7X5G7 | Leishmania donovani | 84% | 100% |
A4I807 | Leishmania infantum | 85% | 100% |
D0AA30 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 94% |
E9B2S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q5D3 | Leishmania major | 85% | 100% |